aprobarbital

Metabolite details

Identifier

UORJNBVJVRLXMQ-UHFFFAOYSA-N

InChI Key

UORJNBVJVRLXMQ-UHFFFAOYSA-N

IUPAC name

5-(propan-2-yl)-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione

Preferred name

aprobarbital

INN name

—

Synonym

5-allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione

ChEBI

CHEBI:2791

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Transcriptomics and metabolomics of engineered Synechococcus elongatus during photomixotrophic growth
• Microbial Diversity and Non-volatile Metabolites Profile of Low-Temperature Sausage Stored at Room Temperature
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• Wild_Type_vs_YQ2-gal
• Control_vs_Day_12
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• CIDP_patient_vs_healthy_control
• Control_vs_BP3_Low_Concentration